Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CECR6 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-15 |
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
mRNA | IRF2BP2 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
mRNA | SATB1 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |